claim
Dasatinib (D), quercetin (Q), and fisetin (F) were chosen for senolytic study because they have established safety profiles or FDA approval for other human purposes, facilitating a faster transition from research to clinical application.
Authors
Sources
- Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com via serper
Referenced by nodes (2)
- Dasatinib concept
- senolytics concept